Abstract
BackgroundTo establish and validate a model to predict somatostatin receptor 2 (SSTR2), vascular endothelial growth factor receptor 2 (VEGFR2), and O6-methylguanine-DNA methyltransferase (MGMT) expression in pancreatic neuroendocrine neoplasms (pNENs) based...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
